Cargando…
Ad-REIC Gene Therapy: Promising Results in a Patient with Metastatic CRPC Following Chemotherapy
A 63-year-old man with metastatic castration-resistant prostate cancer (CRPC) was successfully treated for two years with in situ gene therapy using an adenovirus vector carrying the human REIC/Dkk-3 gene (Ad-REIC), following chemotherapy. Ad-REIC mediates simultaneous induction of cancer-selective...
Autores principales: | Kumon, Hiromi, Sasaki, Katsumi, Ariyoshi, Yuichi, Sadahira, Takuya, Ebara, Shin, Hiraki, Takao, Kanazawa, Susumu, Yanai, Hiroyuki, Watanabe, Masami, Nasu, Yasutomo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373706/ https://www.ncbi.nlm.nih.gov/pubmed/25861236 http://dx.doi.org/10.4137/CMO.S23252 |
Ejemplares similares
-
Feasibility of Neoadjuvant Ad‐REIC Gene Therapy in Patients with High‐Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
por: Kumon, Hiromi, et al.
Publicado: (2015) -
Adenovirus vector carrying REIC/DKK-3 gene: neoadjuvant intraprostatic injection for high-risk localized prostate cancer undergoing radical prostatectomy
por: Kumon, H, et al.
Publicado: (2016) -
Adenovirus-mediated REIC/Dkk-3 gene therapy: Development of an autologous cancer vaccination therapy (Review)
por: WATANABE, MASAMI, et al.
Publicado: (2014) -
Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity
por: Ochiai, Kazuhiko, et al.
Publicado: (2015) -
A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector
por: WATANABE, MASAMI, et al.
Publicado: (2014)